<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Physiology of gonadotropin-releasing hormone</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Physiology of gonadotropin-releasing hormone</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Physiology of gonadotropin-releasing hormone</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Corrine K Welt, MD</a></dd><dt><span> </span>Section Editors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Robert L Barbieri, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">William F Crowley, Jr, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Kathryn A Martin, MD</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Jan 09, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Control of the reproductive axis originates in the hypothalamus with the periodic <strong>pulsatile</strong> release of gonadotropin-releasing hormone (GnRH). In response to GnRH (also called luteinizing hormone-releasing hormone or LHRH), the pituitary releases pulses of the gonadotropins, <strong>luteinizing hormone</strong> (LH) and <strong>follicle-stimulating hormone</strong> (FSH), into the blood stream. These hormones then induce gonadal production of a variety of hormones such as estradiol, progesterone, inhibins, and testosterone that play an important role in the regulation of reproduction.</p><p class="headingAnchor" id="H2"><span class="h1">RELEASE OF GNRH</span><span class="headingEndMark"> — </span>Several elements are necessary for the normal release of and response to GnRH; migration of the secretory neurons via the proper route to the proper location must take place in the developing embryo, and secretion must occur in a pulsatile fashion in response to neuroendocrine inputs and sex steroids.</p><p class="headingAnchor" id="H3"><span class="h2">Embryonic migration</span><span class="headingEndMark"> — </span>GnRH is released from a small number of hypothalamic neurons that appear to arise in the developing embryo from an epithelial cluster of cells in the olfactory placode outside the central nervous system, although evidence in zebrafish suggest the neurons arise from the anterior pituitary placode and cranial neural crest, then transiently associate with the olfactory placode [<a href="#rid1">1-3</a>]. Regardless of their site of origin, fetal cells in the olfactory area can respond to odorant stimuli and secrete GnRH [<a href="#rid4">4</a>]. These neurons then migrate into the olfactory bulb and olfactory tract before continuing to move into the mediobasal hypothalamus in the preoptic area and the arcuate nucleus.</p><p>Migration is an essential feature of developing GnRH neurons, as demonstrated by studies in which the GnRH neurons in fetal hypothalamic tissue were transplanted to the floor of the third ventricle in GnRH-deficient (hpg) mice. The GnRH neurons migrated to the correct hypothalamic location and sent projections to the median eminence [<a href="#rid5">5</a>].</p><p>The critical role of migration has been confirmed in humans in a study of an aborted human fetus with Kallmann syndrome [<a href="#rid6">6</a>]. The fetus had the same X chromosome deletion as its living GnRH-deficient brother. Neuropathological examination showed arrest of the GnRH neurons at the cribriform plate of the ethmoid sinus at a time when the GnRH neurons in a normal fetus would have already migrated to the hypothalamus. These observations facilitated the discovery that anosmin-1, the protein encoded by the <em>KAL1</em> gene responsible for X-linked Kallmann syndrome, plays a role in GnRH neuronal migration [<a href="#rid7">7</a>]. The fibroblast growth factor receptor 1 (<em>FGFR1</em>) also plays a role in GnRH neuronal migration, and mutations in <em>FGFR1</em> and its ligand <em>FGF8</em> are associated with Kallmann syndrome [<a href="#rid8">8-10</a>]. The association of GnRH neurons with the olfactory bulb and tract is thought to explain the high frequency of anosmia (lack of smell) in patients with GnRH deficiency [<a href="#rid11">11,12</a>]. Other gene mutations resulting in GnRH deficiency are reviewed in detail separately. (See  <a class="medical medical_review" href="/d/html/7465.html" rel="external">"Isolated gonadotropin-releasing hormone deficiency (idiopathic hypogonadotropic hypogonadism)"</a>.)</p><p class="headingAnchor" id="H4"><span class="h2">Pulsatile GnRH secretion</span><span class="headingEndMark"> — </span>For proper stimulation of gonadotropin release, GnRH neurons must be properly located and must secrete in a pulsatile fashion (<a class="graphic graphic_waveform graphicRef77183" href="/d/graphic/77183.html" rel="external">waveform 1</a>). Some GnRH neuron axons terminate on cell bodies of other GnRH neurons, suggesting a mechanism for coordinate control of pulsatility [<a href="#rid13">13</a>]. In addition, immortalized GnRH neurons in vitro continue to release GnRH in a pulsatile fashion, suggesting the existence of an intrinsic hypothalamic pulse generator [<a href="#rid14">14</a>].</p><p>Appropriate pulsatile release of GnRH stimulates the release of luteinizing hormone (LH) and follicle-stimulating hormone (FSH). In turn, the pattern of LH and FSH release induces gonadal production of steroid hormones, including the steroids estradiol, progesterone, testosterone, and androstenedione, and other factors, such as the protein hormones inhibin and activin.</p><p>The control of GnRH release is complex. There appears to be a pulse generator that coordinates the secretion of GnRH in discrete, random, but regular bursts. Multiple neurotransmitters and neurohormones have been implicated as having a role in the control of GnRH secretion, including catecholamines, opiates, neuropeptide Y, galanin, corticotropin-releasing hormone, kisspeptin, neurokinin B, dynorphin, and prolactin, as well as gonadal steroids.</p><p>Sex steroids have both positive and negative feedback effects on GnRH pulse frequency. How this occurs is not well understood. Sex steroid receptors have been difficult to identify in hypothalamic GnRH-secreting neurons [<a href="#rid15">15,16</a>] and their existence remains controversial. However, estrogen receptors have been found in adjacent cells in the hypothalamus. Glial cells have steroid hormone receptors and are likely to be intimately involved in transmitting sex steroid feedback (and other signals) to GnRH neurons [<a href="#rid17">17</a>].</p><p>The <em>GPR54</em> gene, which encodes the G-protein coupled kisspeptin receptor, appears to be important for normal hypothalamic GnRH processing or secretion. Mutations in this gene and its ligand kisspeptin have been reported in some patients with congenital GnRH deficiency without anosmia (idiopathic hypogonadotropic hypogonadism [IHH]). Mutations in neurokinin B and its receptor have also been reported in patients with congenital IHH and may work through kisspeptin [<a href="#rid18">18</a>]. (See  <a class="medical medical_review" href="/d/html/7465.html" rel="external">"Isolated gonadotropin-releasing hormone deficiency (idiopathic hypogonadotropic hypogonadism)"</a>.)</p><p class="headingAnchor" id="H5"><span class="h2">Pulsatile gonadotropin response</span><span class="headingEndMark"> — </span>The frequency and amplitude of LH pulses is a crucial component of normal reproductive development and maintenance. On the other hand, disruption of the normal pattern of pulsations is associated with multiple disorders of human reproduction. Thus, understanding the pathophysiology of reproductive disorders requires some assessment of the pulsatility of GnRH secretion. Since the hypothalamus and the portal blood supply are not safely accessible in the human, direct sampling of GnRH is not possible. In addition, measurements of GnRH in the peripheral circulation do not accurately reflect its secretion due to its rapid half-life of two to four minutes [<a href="#rid19">19</a>]. Therefore, serum LH is used as a surrogate marker of hypothalamic GnRH secretion.</p><p>Each pulse of LH measured in the peripheral blood corresponds to a hypothalamic pulse of GnRH into the portal system in a one-to-one relationship (<a class="graphic graphic_waveform graphicRef77183" href="/d/graphic/77183.html" rel="external">waveform 1</a>) [<a href="#rid20">20</a>]. As an example, GnRH-deficient individuals have no pulses of LH detected in their peripheral blood; they will, however, respond to exogenous GnRH with a pulse of LH for each pulse of GnRH given [<a href="#rid21">21</a>]. Prolonged administration of pulses of GnRH in these patients can lead to normal pubertal development and the ability to conceive. Although FSH is released with LH, FSH pulses are much more difficult to detect because the half-life of FSH is longer than the interval between GnRH pulses.</p><p>The requirement for stimulation of the pituitary gonadotrophs to secrete FSH and LH by pulses of GnRH has been documented by frequent blood sampling in many experimental models [<a href="#rid22">22,23</a>] and by the administration of GnRH to GnRH-deficient humans [<a href="#rid21">21</a>]. The response is different if GnRH is administered continuously. With continuous administration, serum gonadotropin concentrations temporarily increase (the agonist effect) and then decrease in response to desensitization (<a class="graphic graphic_figure graphicRef51212" href="/d/graphic/51212.html" rel="external">figure 1</a>) [<a href="#rid21">21,23,24</a>]. The development of desensitization has become <strong>important clinically</strong> as long-acting GnRH agonists (such as <a class="drug drug_general" data-topicid="9549" href="/d/drug information/9549.html" rel="external">leuprolide</a>, <a class="drug drug_general" data-topicid="9673" href="/d/drug information/9673.html" rel="external">nafarelin</a>, or <a class="drug drug_general" data-topicid="8500" href="/d/drug information/8500.html" rel="external">goserelin</a>) are being used to suppress gonadotropin and therefore sex steroid release in a variety of conditions including precocious puberty, prostate cancer, breast cancer, uterine fibroids, and endometriosis [<a href="#rid25">25-29</a>]. When the agonist is withdrawn, spontaneous GnRH pulses resume, leading to restoration of gonadotropin pulsations and gonadal responses.</p><p class="headingAnchor" id="H6"><span class="h1">PHYSIOLOGIC FUNCTIONS</span><span class="headingEndMark"> — </span>The pattern of gonadotropin-releasing hormone (GnRH), luteinizing hormone (LH), and follicle-stimulating hormone (FSH) pulses appears to regulate a variety of important functions including the onset of human sexual differentiation and puberty, as well as adult sex steroid production and fertility.</p><p class="bulletIndent1"><span class="glyph">●</span>In females, FSH promotes follicular development, whereas LH is critical for ovulation, stimulation of androgens (the estradiol precursors) from theca cells, and maintenance of the corpus luteum. (See  <a class="medical medical_review" href="/d/html/7418.html" rel="external">"Normal menstrual cycle"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In males, LH is generally responsible for stimulating testosterone production from the Leydig cells in the testes. FSH, in concert with high intratesticular testosterone levels, is required for spermatogenesis.</p><p></p><p>The ensuing release of gonadal hormones then has modulating effects on both hypothalamic and pituitary function:</p><p class="bulletIndent1"><span class="glyph">●</span>Estradiol, progesterone, and testosterone feedback negatively to reduce the release of LH and FSH; these effects appear to occur at both pituitary and hypothalamic sites of action.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Inhibin suppresses FSH more than LH synthesis and secretion, while activin stimulates FSH release.</p><p></p><p>One can therefore use the combination of serum gonadotropin and sex steroid values to determine if a defect in reproductive function is due to an abnormality of the gonads or to an abnormality in the hypothalamic or pituitary release of gonadotropins.</p><p>Serum sex steroid concentrations will be low in patients with both disorders, but serum gonadotropin concentrations will be high in patients with gonadal dysfunction (due to loss of negative feedback) and low or normal in those with hypothalamic or pituitary disease.</p><p class="headingAnchor" id="H7"><span class="h1">INFORMATION FOR PATIENTS</span><span class="headingEndMark"> — </span>UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5<sup>th</sup> to 6<sup>th</sup> grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10<sup>th</sup> to 12<sup>th</sup> grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.</p><p>Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword(s) of interest.)</p><p class="bulletIndent1"><span class="glyph">●</span>Beyond the Basics topics (see  <a class="medical medical_patient" href="/d/html/8418.html" rel="external">"Patient education: Infertility treatment with gonadotropins (Beyond the Basics)"</a>)</p><p></p><p class="headingAnchor" id="H239062188"><span class="h1">SUMMARY</span><span class="headingEndMark"> — </span>Control of the reproductive axis originates in the hypothalamus with the periodic pulsatile release of gonadotropin-releasing hormone (GnRH). In response to GnRH, the pituitary releases pulses of the gonadotropins, luteinizing hormone (LH), and follicle-stimulating hormone (FSH), into the blood stream. These hormones then induce gonadal production of a variety of hormones, such as estradiol, progesterone, inhibins, and testosterone, that play an important role in the regulation of reproduction.</p><p>The following elements are necessary for the normal hypothalamic secretion of and pituitary response to GnRH:</p><p class="bulletIndent1"><span class="glyph">●</span>GnRH neurons must be properly located; migration of the secretory GnRH neurons takes place in the developing embryo. These neurons then migrate into the olfactory bulb and olfactory tract before continuing to move into the mediobasal hypothalamus in the preoptic area and the arcuate nucleus. (See <a class="local">'Embryonic migration'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>GnRH secretion must occur in a pulsatile fashion in response to neuroendocrine inputs and sex steroids. There appears to be a pulse generator that coordinates the secretion of GnRH in discrete, random, but regular, bursts. (See <a class="local">'Pulsatile GnRH secretion'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The pituitary has an absolute requirement that GnRH secretion be pulsatile in order to secrete LH and FSH (<a class="graphic graphic_waveform graphicRef77183" href="/d/graphic/77183.html" rel="external">waveform 1</a>). Continuous, rather than pulsatile, administration of GnRH results in pituitary desensitization (<a class="graphic graphic_figure graphicRef51212" href="/d/graphic/51212.html" rel="external">figure 1</a>). This observation is the basis for the clinical use of GnRH agonists, which are used to suppress gonadotropin secretion and therefore gonadal steroids in a variety of conditions including precocious puberty, prostate cancer, breast cancer, uterine fibroids, and endometriosis. (See <a class="local">'Pulsatile gonadotropin response'</a> above.)</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Schwanzel-Fukuda M, Jorgenson KL, Bergen HT, et al. Biology of normal luteinizing hormone-releasing hormone neurons during and after their migration from olfactory placode. Endocr Rev 1992; 13:623.</a></li><li><a class="nounderline abstract_t">Schwanzel-Fukuda M, Pfaff DW. Origin of luteinizing hormone-releasing hormone neurons. Nature 1989; 338:161.</a></li><li><a class="nounderline abstract_t">Whitlock KE. Origin and development of GnRH neurons. Trends Endocrinol Metab 2005; 16:145.</a></li><li><a class="nounderline abstract_t">Barni T, Maggi M, Fantoni G, et al. Sex steroids and odorants modulate gonadotropin-releasing hormone secretion in primary cultures of human olfactory cells. J Clin Endocrinol Metab 1999; 84:4266.</a></li><li><a class="nounderline abstract_t">Gibson MJ, Krieger DT, Charlton HM, et al. Mating and pregnancy can occur in genetically hypogonadal mice with preoptic area brain grafts. Science 1984; 225:949.</a></li><li><a class="nounderline abstract_t">Schwanzel-Fukuda M, Bick D, Pfaff DW. Luteinizing hormone-releasing hormone (LHRH)-expressing cells do not migrate normally in an inherited hypogonadal (Kallmann) syndrome. Brain Res Mol Brain Res 1989; 6:311.</a></li><li><a class="nounderline abstract_t">Soussi-Yanicostas N, Faivre-Sarrailh C, Hardelin JP, et al. Anosmin-1 underlying the X chromosome-linked Kallmann syndrome is an adhesion molecule that can modulate neurite growth in a cell-type specific manner. J Cell Sci 1998; 111 ( Pt 19):2953.</a></li><li><a class="nounderline abstract_t">Tsai PS, Moenter SM, Postigo HR, et al. Targeted expression of a dominant-negative fibroblast growth factor (FGF) receptor in gonadotropin-releasing hormone (GnRH) neurons reduces FGF responsiveness and the size of GnRH neuronal population. Mol Endocrinol 2005; 19:225.</a></li><li><a class="nounderline abstract_t">Dodé C, Levilliers J, Dupont JM, et al. Loss-of-function mutations in FGFR1 cause autosomal dominant Kallmann syndrome. Nat Genet 2003; 33:463.</a></li><li><a class="nounderline abstract_t">Falardeau J, Chung WC, Beenken A, et al. Decreased FGF8 signaling causes deficiency of gonadotropin-releasing hormone in humans and mice. J Clin Invest 2008; 118:2822.</a></li><li><a class="nounderline abstract_t">Spratt DI, Carr DB, Merriam GR, et al. The spectrum of abnormal patterns of gonadotropin-releasing hormone secretion in men with idiopathic hypogonadotropic hypogonadism: clinical and laboratory correlations. J Clin Endocrinol Metab 1987; 64:283.</a></li><li><a class="nounderline abstract_t">Kallmann FJ, Schoenfeld WA, Barrera SE. The genetic aspects of primary eunuchoidism. Am J Mental Def 1944; 48:203.</a></li><li><a class="nounderline abstract_t">Chen WP, Witkin JW, Silverman AJ. beta-Endorphin and gonadotropin-releasing hormone synaptic input to gonadotropin-releasing hormone neurosecretory cells in the male rat. J Comp Neurol 1989; 286:85.</a></li><li><a class="nounderline abstract_t">Wetsel WC, Valença MM, Merchenthaler I, et al. Intrinsic pulsatile secretory activity of immortalized luteinizing hormone-releasing hormone-secreting neurons. Proc Natl Acad Sci U S A 1992; 89:4149.</a></li><li><a class="nounderline abstract_t">Skynner MJ, Sim JA, Herbison AE. Detection of estrogen receptor alpha and beta messenger ribonucleic acids in adult gonadotropin-releasing hormone neurons. Endocrinology 1999; 140:5195.</a></li><li><a class="nounderline abstract_t">Roy D, Angelini NL, Belsham DD. Estrogen directly respresses gonadotropin-releasing hormone (GnRH) gene expression in estrogen receptor-alpha (ERalpha)- and ERbeta-expressing GT1-7 GnRH neurons. Endocrinology 1999; 140:5045.</a></li><li><a class="nounderline abstract_t">Ojeda SR, Ma YJ. Glial-neuronal interactions in the neuroendocrine control of mammalian puberty: facilitatory effects of gonadal steroids. J Neurobiol 1999; 40:528.</a></li><li><a class="nounderline abstract_t">Topaloglu AK, Reimann F, Guclu M, et al. TAC3 and TACR3 mutations in familial hypogonadotropic hypogonadism reveal a key role for Neurokinin B in the central control of reproduction. Nat Genet 2009; 41:354.</a></li><li><a class="nounderline abstract_t">Pimstone B, Epstein S, Hamilton SM, et al. Metabolic clearance and plasma half disappearance time of exogenous gonadotropin releasing hormone in normal subjects and in patients with liver disease and chronic renal failure. J Clin Endocrinol Metab 1977; 44:356.</a></li><li><a class="nounderline abstract_t">Clarke IJ. Variable patterns of gonadotropin-releasing hormone secretion during the estrogen-induced luteinizing hormone surge in ovariectomized ewes. Endocrinology 1993; 133:1624.</a></li><li><a class="nounderline abstract_t">Crowley WF Jr, Filicori M, Spratt DI, Santoro NF. The physiology of gonadotropin-releasing hormone (GnRH) secretion in men and women. Recent Prog Horm Res 1985; 41:473.</a></li><li><a class="nounderline abstract_t">Weiss J, Duca KA, Crowley WF Jr. Gonadotropin-releasing hormone-induced stimulation and desensitization of free alpha-subunit secretion mirrors luteinizing hormone and follicle-stimulating hormone in perifused rat pituitary cells. Endocrinology 1990; 127:2364.</a></li><li><a class="nounderline abstract_t">Belchetz PE, Plant TM, Nakai Y, et al. Hypophysial responses to continuous and intermittent delivery of hypopthalamic gonadotropin-releasing hormone. Science 1978; 202:631.</a></li><li><a class="nounderline abstract_t">Conn PM, Crowley WF Jr. Gonadotropin-releasing hormone and its analogues. N Engl J Med 1991; 324:93.</a></li><li><a class="nounderline abstract_t">Crowley WF Jr, Comite F, Vale W, et al. Therapeutic use of pituitary desensitization with a long-acting lhrh agonist: a potential new treatment for idiopathic precocious puberty. J Clin Endocrinol Metab 1981; 52:370.</a></li><li><a class="nounderline abstract_t">Labrie F, Dupont A, Bélanger A, et al. Treatment of prostate cancer with gonadotropin-releasing hormone agonists. Endocr Rev 1986; 7:67.</a></li><li><a class="nounderline abstract_t">Klijn JG, de Jong FH, Lamberts SW, Blankenstein MA. LHRH-agonist treatment in clinical and experimental human breast cancer. J Steroid Biochem 1985; 23:867.</a></li><li><a class="nounderline abstract_t">Filicori M, Hall DA, Loughlin JS, et al. A conservative approach to the management of uterine leiomyoma: pituitary desensitization by a luteinizing hormone-releasing hormone analogue. Am J Obstet Gynecol 1983; 147:726.</a></li><li><a class="nounderline abstract_t">Barbieri RL. New therapy for endometriosis. N Engl J Med 1988; 318:512.</a></li></ol></div><div id="topicVersionRevision">Topic 7438 Version 17.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1459046" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Biology of normal luteinizing hormone-releasing hormone neurons during and after their migration from olfactory placode.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2645530" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Origin of luteinizing hormone-releasing hormone neurons.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15860410" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Origin and development of GnRH neurons.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10566683" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Sex steroids and odorants modulate gonadotropin-releasing hormone secretion in primary cultures of human olfactory cells.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6382608" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Mating and pregnancy can occur in genetically hypogonadal mice with preoptic area brain grafts.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2687610" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Luteinizing hormone-releasing hormone (LHRH)-expressing cells do not migrate normally in an inherited hypogonadal (Kallmann) syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9730987" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Anosmin-1 underlying the X chromosome-linked Kallmann syndrome is an adhesion molecule that can modulate neurite growth in a cell-type specific manner.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15459253" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Targeted expression of a dominant-negative fibroblast growth factor (FGF) receptor in gonadotropin-releasing hormone (GnRH) neurons reduces FGF responsiveness and the size of GnRH neuronal population.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12627230" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Loss-of-function mutations in FGFR1 cause autosomal dominant Kallmann syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18596921" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Decreased FGF8 signaling causes deficiency of gonadotropin-releasing hormone in humans and mice.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3098771" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : The spectrum of abnormal patterns of gonadotropin-releasing hormone secretion in men with idiopathic hypogonadotropic hypogonadism: clinical and laboratory correlations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : The genetic aspects of primary eunuchoidism</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2671062" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : beta-Endorphin and gonadotropin-releasing hormone synaptic input to gonadotropin-releasing hormone neurosecretory cells in the male rat.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1570341" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Intrinsic pulsatile secretory activity of immortalized luteinizing hormone-releasing hormone-secreting neurons.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10537149" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Detection of estrogen receptor alpha and beta messenger ribonucleic acids in adult gonadotropin-releasing hormone neurons.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10537130" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Estrogen directly respresses gonadotropin-releasing hormone (GnRH) gene expression in estrogen receptor-alpha (ERalpha)- and ERbeta-expressing GT1-7 GnRH neurons.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10453054" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Glial-neuronal interactions in the neuroendocrine control of mammalian puberty: facilitatory effects of gonadal steroids.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19079066" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : TAC3 and TACR3 mutations in familial hypogonadotropic hypogonadism reveal a key role for Neurokinin B in the central control of reproduction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/320223" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Metabolic clearance and plasma half disappearance time of exogenous gonadotropin releasing hormone in normal subjects and in patients with liver disease and chronic renal failure.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8404603" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Variable patterns of gonadotropin-releasing hormone secretion during the estrogen-induced luteinizing hormone surge in ovariectomized ewes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3931190" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : The physiology of gonadotropin-releasing hormone (GnRH) secretion in men and women.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2121462" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Gonadotropin-releasing hormone-induced stimulation and desensitization of free alpha-subunit secretion mirrors luteinizing hormone and follicle-stimulating hormone in perifused rat pituitary cells.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/100883" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Hypophysial responses to continuous and intermittent delivery of hypopthalamic gonadotropin-releasing hormone.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1984190" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Gonadotropin-releasing hormone and its analogues.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6780592" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Therapeutic use of pituitary desensitization with a long-acting lhrh agonist: a potential new treatment for idiopathic precocious puberty.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3514203" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Treatment of prostate cancer with gonadotropin-releasing hormone agonists.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3935869" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : LHRH-agonist treatment in clinical and experimental human breast cancer.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6356927" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : A conservative approach to the management of uterine leiomyoma: pituitary desensitization by a luteinizing hormone-releasing hormone analogue.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2963214" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : New therapy for endometriosis.</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
